RiverPark Advisors’s SeaStar Medical ICU Stock Holding History

RiverPark Advisors’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-53	Closed	-$136K	–	100
2022 Q3	$136K	Hold	53	–	–	0.04%	116
2022 Q2	$135K	Hold	53	–	–	0.04%	106
2022 Q1	$134K	Hold	53	–	–	0.02%	147
2021 Q4	$133K	Buy	53 +18	+51%	+$45K	0.02%	175
2021 Q3	$88K	Buy	+35	New	+$86.7K	0.01%	159

Other funds holding ICU

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CCFM

Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return

SWA

SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RiverPark Advisors's ICU Position: Q4 2022 in Review

RiverPark Advisors sold out of SeaStar Medical (ICU) in Q4 2022, closing a stake of 53 shares — an estimated $136K sold.

RiverPark Advisors first reported a position in ICU in Q3 2021 and held it in 5 quarters. The position peaked at $136K in Q3 2022. 8 funds tracked by Wall St. Rank hold ICU as of Q4 2022.

RiverPark Advisors reported no remaining SeaStar Medical position as of Q4 2022 after selling out during the quarter.
RiverPark Advisors sold 53 SeaStar Medical shares in Q4 2022, an estimated $136K.
RiverPark Advisors first reported a position in SeaStar Medical in Q3 2021 and held it in 5 quarters.
RiverPark Advisors's SeaStar Medical position peaked at $136K in Q3 2022.
8 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2022.

Based on RiverPark Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.